Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
About this item
Full title
Author / Creator
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
Summary
Peritoneal dissemination occurs frequently in patients with unresectable advanced-stage gastric cancer. In this study, we tested the efficacy of the mTOR inhibitor RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination. Using the two cell lines, 58As1, a cell line exhibiting a high propensity for peritoneal met...
Alternative Titles
Full title
Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_889452711
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_889452711
Other Identifiers
ISSN
0167-6997,1573-0646
E-ISSN
1573-0646
DOI
10.1007/s10637-010-9464-9
